Chemical synthesis could produce more potent antibiotics

November 5, 2018, Massachusetts Institute of Technology
Credit: CC0 Public Domain

Using a novel type of chemical reaction, MIT researchers have shown that they can modify antibiotics in a way that could potentially make them more effective against drug-resistant infections.

By chemically linking the antibiotic vancomycin to an antimicrobial peptide, the researchers were able to dramatically enhance the drug's effectiveness against two strains of drug-resistant bacteria. This kind of modification is simple to perform and could be used to create additional combinations of antibiotics and , the researchers say.

"Typically, a lot of steps would be needed to get vancomycin in a form that would allow you to attach it to something else, but we don't have to do anything to the drug," says Brad Pentelute, an MIT associate professor of chemistry and the study's senior author. "We just mix them together and we get a conjugation reaction."

This strategy could also be used to modify other types of drugs, including cancer drugs, Pentelute says. Attaching such drugs to an antibody or another targeting protein could make it easier for the drugs to reach their intended destinations.

Pentelute's lab worked with Stephen Buchwald, the Camille Dreyfus Professor of Chemistry at MIT; Scott Miller, a professor of chemistry at Yale University; and researchers at Visterra, a local biotech company, on the paper, which appears in the Nov. 5 issue of Nature Chemistry. The paper's lead authors are former MIT postdoc Daniel Cohen, MIT postdoc Chi Zhang, and MIT graduate student Colin Fadzen.

A simple reaction

Several years ago, Cohen made the serendipitous discovery that an amino acid called selenocysteine can spontaneously react with complex natural compounds without the need for a metal catalyst. Cohen found that when he mixed electron-deficient selenocysteine with the antibiotic vancomycin, the selenocysteine attached itself to a particular spot—an electron-rich ring of carbon atoms within the vancomycin molecule.

This led the researchers to try using selenocysteine as a "handle" that could be used to link peptides and small-molecule drugs. They incorporated selenocysteine into naturally occurring antimicrobial peptides—small proteins that most organisms produce as part of their immune defenses. Selenocysteine, a naturally occurring amino acid that includes an atom of selenium, is not as common as the other 20 but is found in a handful of enzymes in humans and other organisms.

The researchers found that not only were these peptides able to link up with vancomycin, but the chemical bonds consistently occurred at the same location, so all of the resulting molecules were identical. Creating such a pure product is difficult with existing methods for linking complex molecules. Furthermore, doing this kind of reaction with previously existing methods would likely require 10 to 15 steps just to chemically modify vancomycin in a way that would allow it to react with a peptide, the researchers say.

"That's the beauty of this method," Zhang says. "These complex molecules intrinsically possess regions that can be harnessed to conjugate to our protein, if the protein possesses the selenocysteine handle that we developed. It can greatly simplify the process."

The researchers tested conjugates of vancomycin and a variety of antimicrobial peptides (AMPs). They found that one of these molecules, a combination of vancomycin and the AMP dermaseptin, was five times more powerful than vancomycin alone against a strain of bacteria called E. faecalis. Vancomycin linked to an AMP called RP-1 was able to kill the bacterium A. baumannii, even though alone has no effect on this strain. Both of these strains have high levels of resistance and often cause infections acquired in hospitals.

Modified drugs

This approach should work for linking peptides to any complex organic molecule that has the right kind of electron-rich ring, the researchers say. They have tested their method with about 30 other molecules, including serotonin and resveratrol, and found that they could be easily joined to peptides containing selenocysteine. The researchers have not yet explored how these modifications might affect the drugs' activity.

In addition to modifying antibiotics, as they did in this study, the researchers believe they could use this technique for creating targeted cancer drugs. Scientists could use this approach to attach antibodies or other proteins to , helping the drugs to reach their destination without causing side effects in healthy tissue.

Adding selenocysteine to small peptides is a fairly straightforward process, the say, but they are now working on adapting the method so that it can be used for larger proteins. They are also experimenting with the possibility of performing this type of conjugation reaction using the more common amino acid cysteine as a handle instead of .

Explore further: Supercharged antibiotics could turn tide against superbugs

More information: A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins, Nature Chemistry (2018). DOI: 10.1038/s41557-018-0154-0 , https://www.nature.com/articles/s41557-018-0154-0

Related Stories

New antibiotic packs a punch against bacterial resistance

May 29, 2017

Scientists at The Scripps Research Institute (TSRI) have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come. ...

Recommended for you

Researchers report breakthrough in ice-repelling materials

January 15, 2019

Icy weather is blamed for multibillion dollar losses every year in the United States, including delays and damage related to air travel, infrastructure and power generation and transmission facilities. Finding effective, ...

Research finds serious problems with forensic software

January 15, 2019

New research from North Carolina State University and the University of South Florida finds significant flaws in recently released forensic software designed to assess the age of individuals based on their skeletal remains. ...

The secret to Rembrandt's impasto unveiled

January 15, 2019

Impasto is thick paint laid on the canvas in an amount that makes it stand from the surface. The relief of impasto increases the perceptibility of the paint by increasing its light-reflecting textural properties. Scientists ...

Researchers gain control over soft-molecule synthesis

January 14, 2019

By gaining control over shape, size and composition during synthetic molecule assembly, researchers can begin to probe how these factors influence the function of soft materials. Finding these answers could help advance virology, ...

Marine bacterium sheds light on control of toxic metals

January 14, 2019

An ocean-dwelling bacterium has provided fresh insights into how cells protect themselves from the toxic effects of metal ions such as iron and copper, in research led by the University of East Anglia (UEA).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.